Seeing Machines is an award winning technology company with a focus on vision based human machine interfaces. Seeing Machines technology platform is based on world-leading computer vision processing technologies that allow machines to see and track human faces and certain facial features. These technologies enable the development of new cutting edge products and applications, ranging from devices that improve road safety & save lives, to those that help manage eye disease and prevent loss of eyesight.
The company’s focus is on deploying its computer vision technologies, worldwide, in:
- Driver/operator safety products for transport markets through the DSS product range;
- The TrueField Analyzer® (TFA) product for vision testing devices for healthcare markets;
- New products in a range of markets including sports, entertainment, robotics and security through our faceAPI product; and
- Human performance measurement through our faceLAB® product.
All RNS Press Releases RNS Release - Significant Shareholder Notification
3rd Feb 2012, 7:00 am
RNS Number : 7496W
Seeing Machines Limited
03 February 2012
Seeing Machines Limited
("Seeing Machines" or the "Company")
Significant Shareholder Notification
The Company received advice on 2 February 2012 from the Royal Bank of Canada, that following a transaction on 27 January
2012, the shareholding of RBC Trustees (CI) Limited has changed as follows:
| Situation Previous to Transaction | Situation Following Transaction |
Class/type of shares | Number of Shares | Number of Voting rights | Number of Shares | Number of Voting Rights (indirect) |
Ordinary | 22,494,046 | 22,494,046 | 24,994,046 | 24,994,046 |
RBC Trustees (CI) Limited therefore controls voting rights over ordinary shares representing 6.11% of the shares on
issue.
---ENDS---
Seeing Machines Limited | Ken Kroeger, CEO | +61 (2) 6103
4700 |
Daniel Stewart & Company plc | David Hart/James
Thomas | +44 (0) 20 7776 6550 |
Walbrook PR Ltd
|
Bob Huxford
Helen Westaway | +44 (0) 20 7933 8780 +44 (0) 7980 541 893 or bob.huxford@walbrookpr.com +44 (0) 7841 917 679 or helen.westaway@walbrookpr.com |
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLQXLBBLLFXBBK
No investment advice
The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.
You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
